Social Cognition Training in Schizophrenia

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2012 by Oslo University Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Anja Vaskinn, Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT01206842
First received: September 10, 2010
Last updated: January 2, 2012
Last verified: January 2012
  Purpose

People with schizophrenia show deficits in social cognition, the ability to process information about other people such as identifying their emotional expressions. Social cognition is associated with everyday life functioning and could therefore be an important treatment target. Several social cognitive training programs have been developed during the last years. Results indicate that social cognitive performance can be ameliorated through commonly used intervention techniques. However, it is less clear whether this improvement generalizes to everyday life. The purpose of this study is to investigate if a social cognitive training program (Training in Affect Recognition) improves performance on social cognitive and neuropsychological tests and leads to improved everyday life functioning in persons with schizophrenia. The study also aims at examining if an improvement is present three months after completion of the training intervention.


Condition Intervention
Schizophrenia
Social Cognition
Other: Training in Affect Recognition

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
Official Title: Social Cognition Training in Schizophrenia

Resource links provided by NLM:


Further study details as provided by Oslo University Hospital:

Primary Outcome Measures:
  • Social cognitive tests [ Time Frame: Within one week and within three months of completed training ] [ Designated as safety issue: No ]
    PFA and MASC


Secondary Outcome Measures:
  • Functional capacity tests [ Time Frame: Within one week and within three months of completed training ] [ Designated as safety issue: No ]
    AIPSS and UPSA-brief

  • Neuropsychological tests [ Time Frame: Within one week and within three months of completed training ] [ Designated as safety issue: No ]
    MATRICS


Estimated Enrollment: 25
Study Start Date: August 2011
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: social cognition training Other: Training in Affect Recognition
A 12-session social cognitive training programming covering emotion perception and social perception administered in a group setting to up to four participants with schizophrenia at the time

  Eligibility

Ages Eligible for Study:   18 Years to 55 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • age 18-55
  • diagnosis of schizophrenia or schizoaffective disorder
  • IQ > 69
  • sufficient mastery of Norwegian to undergo assessments

Exclusion Criteria:

  • history of head trauma
  • neurological/medical condition known to interfere with central nervous system
  • receiving outpatient care at time of recruitment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01206842

Contacts
Contact: Anja Vaskinn, PhD +4722923908 anja.vaskinn@medisin.uio.no

Locations
Norway
Oslo University Hospital Recruiting
Oslo, Norway, 0424
Contact: Anja Vaskinn, PhD    +4722923908    anja.vaskinn@medisin.uio.no   
Principal Investigator: Anja Vaskinn, PhD         
Sponsors and Collaborators
Oslo University Hospital
Investigators
Principal Investigator: Anja Vaskinn, PhD Oslo University Hospital, Psychosis Research Unit
  More Information

No publications provided

Responsible Party: Anja Vaskinn, PhD, Oslo University Hospital
ClinicalTrials.gov Identifier: NCT01206842     History of Changes
Other Study ID Numbers: 2010/1538 (REK)
Study First Received: September 10, 2010
Last Updated: January 2, 2012
Health Authority: Norway:National Committee for Medical and Health Research Ethics

Keywords provided by Oslo University Hospital:
functional capacity
training
neurocognition

Additional relevant MeSH terms:
Schizophrenia
Schizophrenia and Disorders with Psychotic Features
Mental Disorders

ClinicalTrials.gov processed this record on July 31, 2014